HLA class II polymorphism in cystic fibrosis: A possible modifier of pulmonary phenotype

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 5 I, 1999, Pages 1464-1468

  Aron, Yolande ^a   Polla, Barbara S ^a   Bienvenu, Thierry ^a   Dall'Ava, Josette ^a   Dusser, Daniel ^a   Hubert, Dominique ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN E;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; LUNG INJURY; MALE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 0032935226     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.5.9807046     Document Type: Article

References (33)

1. Kerem, B., J. M. Rommens, J. A. Buchanan, D. Markicwicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L. C. Tsui. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
2. Zielenski, J., and L. C. Tsui. 1995. Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29:777-807.
3. Kerem, B., and E. Kerem. 1996. The molecular basis for disease variability in cystic fibrosis. Eur. J. Hum. Genet. 4:65-73.
4. Rozmahel, R., M. Wilchanski, A. Matin, S. Plyte, M. Olivier, W. Auerbach, A. Moore, J. Forstner, P. Durie, J. Nadeau, C. Bear, and L. C. Tsui. 1996. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nature Genet. 12:280-287.
5. Rozmahel, R., M. Corey, J. Zielenski, G. Kent, C. Bear, P. Durie, and L. C. Tsui. 1997. Genetic approach to CF modifiers. 11th North American Annual Cystic Fibrosis Conference, Nashville, 23-26 October 1997. Pediatr. Pulmonol. 246(Suppl. 14):175-176.
6. Tobin, M. J., O. Maguire, D. Reen, E. Tempany, and M. X. Fitzgerald. 1980. Atopy and bronchial reactivity in older patients with cystic fibrosis. Thorax 35:807-813.
7. Warner, J. O., B. W. Taylor, A. P. Norman, and J. F. Soothill. 1976. Association of cystic fibrosis with allergy. Arch. Dis. Child. 51:507-511.
8. Fischer, G. F., W. F. Pickl, I. Fae, C. Ebner, F. Ferreira, H. Breitteneder, E. Vikoukal, O. Scheiner, and D. Kraft. 1992. Association between IgE response against Bet v 1, the major allergen of birch pollen and HLA-DRB1 alleles. Human Immunol. 33:259-265.
9. Aron, Y., E. Swierczewski, and A. Lockhart. 1994. A simple and rapid micromethod for genomic DNA extraction from jugal epithelial cells: application to human lymphocyte antigen typing in one large family of atopic/asthmatic probands. Allergy 49:788-790.
10. Aron, Y., E. Swierczewski, and A. Lockhart. 1995. HLA class II haplotype in atopic asthmatic and non-atopic control subjects. Clin. Exp. Allergy 25: 65-67.
11. Aron, Y., N. Desmazes-Dufeu, R. Matran, B. S. Polla, D. Dusser, A. Lockhart, and E. Swierczewski. 1996. Evidence of a strong positive association between atopy and the HLA class II alleles DR4 and DR7. Clin. Exp. Allergy 26:821-828.
12. Wang, D., G. M. Levasseur-Acker., R. Jankowski, G. Kanny, D. A. Monneret-Vautrin, D. Charron, A. Lockhart, and E. Swierczewski. 1997. HLA class II antigens and T lymphocytes in human nasal epithelial cells: modulation of the HLA class II gene transcripts by gamma interferon. Clin. Exp. Allergy 27:306-14.
13. Sandford, A., T. Weir, and P. Paré. 1996. The genetics of asthma. Am. J. Respir. Crit. Care Med. 153:1749-1765.
14. Colombani, J. 1993. HLA. Fonctions Immunitaires et Applications Médicales. John Libbey Eurotex, Paris. 1-285.
15. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 9.14-9.23.
16. Bienvenu, T., C. Cazeneuve, J. C. Kaplan, and C. Beldjord. 1995. Mutation heterogeneity of cystic fibrosis in France: screening by denaturing gradient gel electrophoresis using psoralen-modified oligonucleotide. Hum. Genet. 6:23-29.
17. Bignon, J. S., Y. Aron, L. Y. Ju, M. C. Kopferschmitt, R. Garnier, C. Mapp, L. M. Fabbri, G. Pauli, A. Lockhart, D. Charron, and E. Swierczewski. 1994. HLA class II alleles in isocyanate-induced asthma. Am. J. Respir. Crit. Care Med. 149:71-75.
18. Haldane, J. B. S. 1956. The estimation and significance of the logarithm of a ratio of frequencies. Ann. Hum. Genet. 20:309-311.
19. Bussort, M., and P. Prevost. 1986. Contribution of statistics to the study of association and linkage between HLA and diseases. Path. Biol. 34: 711-714.
20. The Cystic Fibrosis Genotype-Phenotype Consortium. 1993. Correlation between genotype and phenotype in patients with cystic fibrosis. N. Engl. J. Med. 325:1630-1634.
21. Kaufman, J. F., C. Aufray, A. J. Korman, D. A. Shackleford, and J. Strominger. 1984. The class II molecules of the human and murine major histocompatibility complex. Cell 36:1-13.
22. Berlin, M., A. Fogdell-Hahn, O. Olerup, A. Eklund, and J. Grunewald. 1997. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med. 56:1601-1605.
23. Hennequet, A., M. Jehanne, H. Betuel, R. Gilly, M. Schmid, and J. Hors. 1978. Cystic fibrosis and HLA. Tissue Antigens 12:159-162.
24. Turner, M. W., J. O. Warner, C. R. Stokes, and P. Norman. 1978. Immunological studies in cystic fibrosis. Arch. Dis. Child. 53:631-638.
25. Jones, M. M., D. K. Seilheimer, M. S. Pollack, M. Curry, M. M. Crane, and R. D. Rossen. 1989. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am. Rev. Respir. Dis. 140:1636-1639.
26. Carrington, M., L. J. Krueger, D. S. Holsclaw, M. C. Iannuzzi, Jr., M. Dean, and D. Mann. 1994. Cystic fibrosis diabetes is associated with HLA DQB1 alleles encoding Asp-57 molecules. J. Clin. Immunol. 14: 353-358.
27. Hata, J. S., and R. B. Fick, Jr. 1988. Pseudomonas aeruginosa and the airway disease of cystic fibrosis. Clin. Chest Med. 9:679-689.
28. Meyer, C. G., J. May, and K. Stark. 1998. Human leucocyte antigens in tuberculosis and leprosis. Trends Microbiol. 6:148-154.
29. Kubesch, P., T. Dörk, U. Wulbrandt, N. Kälin, T. Neumann, B. Wulf, H. Geerlings, H. Weissbrodt, H. von der Hardt, and B. Tümmler, 1993. Genetic determinants of airways' colonization with Pseudomonas aeruginosa in cystic fibrosis. Lancet 341:189-193.
30. Ballman, M., I. Bronsfeld, J. Bijman, U. Laabs, F. Mekus, H. Veeze, and B. Tummler, and the European Cystic Fibrosis Twin and Sibling Study Group. 1994. Variability of clinical phenotype in twins and siblings with cystic fibrosis: first epidemiological results of the European cystic fibrosis twin and sibling study. 11th North American Annual Cystic Fibrosis Conference, Nashville, 23-26 October 1997. Pediatr. Pulmonol. 246(Suppl. 14):247(abstr 137).
31. Cardaba, B., R. De Pablo, C. Vilches, E. Martin, C. Geller-Bernstein, B. De Andres, Y. Zaharan, V. Del Pozo, S. Gallardo, E. De Arruda Chaves, Y. Waisel, P. Palomino, M. Kreisler, and C. Lahoz. 1996. Allergy to olive pollen: T-cell response from olive allergic patients is restricted by DR7-DQ2 antigens. Clin. Exp. Allergy 26:316-322.
32. Rachelefsky, G. S., A. Osher, R. E. Dooley, B. Ank, and R. Stiehm. 1974. Coexistent respiratory allergy and cystic fibrosis. Am. J. Dis. Child. 128:355-359.
33. Pitcher-Wilmott, R. W., R. J. Levinsky, I. Gordon, M. W. Turner, and D. J. Matthew. 1982. Pseudomonas infection, allergy and cystic fibrosis. Arch. Dis. Child. 57:582-586.